Cargando…

Plasma metabolomics of schizophrenia with cognitive impairment: A pilot study

Schizophrenia (SCZ) acts as a complex and burdensome disease, in which the functional outcome can be validly predicted by cognitive impairment, as one of the core features. However, there still lack considerable markers of cognitive deficits in SCZ. Based on metabolomics, it is expected to identify...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Yihe, Sun, Xiujia, Hu, Miaowen, Zhang, Lei, Zhao, Nan, Shen, Yifeng, Yu, Shunying, Huang, Jingjing, Li, Huafang, Yu, Wenjuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554540/ https://www.ncbi.nlm.nih.gov/pubmed/36245866 http://dx.doi.org/10.3389/fpsyt.2022.950602

Ejemplares similares

Safety and related factors of treatment with long-term atypical antipsychotic in Chinese patients with schizophrenia: observational study
por: Yu, Wenjuan, et al.
Publicado: (2021)

Association of Cognitive Impairment With Anhedonia in Patients With Schizophrenia
por: Yu, Lingfang, et al.
Publicado: (2021)

Hair Cortisol Is Associated With Social Support and Symptoms in Schizophrenia
por: Yang, Fuzhong, et al.
Publicado: (2020)

Cognitive Impairment and Psychopathology Are Related to Plasma Oxidative Stress in Long Term Hospitalized Patients With Chronic Schizophrenia
por: Yang, Man, et al.
Publicado: (2022)

Sex differences between serum total bilirubin levels and cognition in patients with schizophrenia
por: He, Shen, et al.
Publicado: (2021)

The Use of Cognitive Screening in Pharmacotherapy Trials for Cognitive Impairment Associated With Schizophrenia
por: Cotter, Jack, et al.
Publicado: (2019)

Treatment Responses of Cognitive Function and Plasma Asymmetric Dimethylarginine to Atypical Antipsychotic in Patients With Schizophrenia
por: Yu, Zhi-min, et al.
Publicado: (2019)

Cognitive Impairment in Bipolar Disorder and Schizophrenia: A Systematic Review
por: Vöhringer, Paul A., et al.
Publicado: (2013)

Self-Awareness Deficits of Cognitive Impairment in Individuals With Schizophrenia. Really?
por: Raffard, Stéphane, et al.
Publicado: (2020)

Decreased Peripheral BDNF Levels and Cognitive Impairment in Late-Life Schizophrenia
por: Huo, Lijuan, et al.
Publicado: (2021)

Alterations of cerebellar white matter integrity and associations with cognitive impairments in schizophrenia
por: Chang, Xuebin, et al.
Publicado: (2022)

Upregulation of DGCR8, a Candidate Predisposing to Schizophrenia in Han Chinese, Contributes to Phenotypic Deficits and Neuronal Migration Delay
por: Bi, Yan, et al.
Publicado: (2022)

A Serious Game to Improve Cognitive Functions in Schizophrenia: A Pilot Study
por: Amado, Isabelle, et al.
Publicado: (2016)

Autoimmune Encephalitis With Psychotic Manifestations and Cognitive Impairment Presenting as Schizophrenia: Case Report and Literature Review
por: Luo, Yuanyuan, et al.
Publicado: (2022)

Study on risk factors of extrapyramidal symptoms induced by antipsychotics and its correlation with symptoms of schizophrenia
por: Weng, Jiajun, et al.
Publicado: (2019)

Neural Correlates for Intrinsic Motivational Deficits of Schizophrenia; Implications for Therapeutics of Cognitive Impairment
por: Takeda, Kazuyoshi, et al.
Publicado: (2018)

Prevalence, Influencing Factors, and Clinical Characteristics of Cognitive Impairment in Elderly Patients With Schizophrenia
por: Liu, Guojun, et al.
Publicado: (2022)

Accelerated Global and Local Brain Aging Differentiate Cognitively Impaired From Cognitively Spared Patients With Schizophrenia
por: Haas, Shalaila S., et al.
Publicado: (2022)

Adverse childhood experiences in patients with schizophrenia: related factors and clinical implications
por: Zhang, Lei, et al.
Publicado: (2023)

Assessing Social Cognition of Persons with Schizophrenia in a Chinese Population: A Pilot Study
por: Lo, Panmi M. T., et al.
Publicado: (2018)

Baseline Serum Levels of Beclin-1, but Not Inflammatory Factors, May Predict Antidepressant Treatment Response in Chinese Han Patients With MDD: A Preliminary Study
por: He, Shen, et al.
Publicado: (2019)

Decreased Plasma Levels of Growth Differentiation Factor 11 in Patients With Schizophrenia: Correlation With Psychopathology and Cognition
por: Yang, Zhao-xi, et al.
Publicado: (2020)

A Metabolomics Study of Serum in Hospitalized Patients With Chronic Schizophrenia
por: Okamoto, Naomichi, et al.
Publicado: (2021)

Decreased plasma neuropeptides in first-episode schizophrenia, bipolar disorder, major depressive disorder: associations with clinical symptoms and cognitive function
por: Yu, Hua, et al.
Publicado: (2023)

Transcranial direct current stimulation of the occipital lobes with adjunct lithium attenuates the progression of cognitive impairment in patients with first episode schizophrenia
por: Zhuo, Chuanjun, et al.
Publicado: (2022)

Long-Term Antipsychotic Effectiveness and Comparison of the Efficacy of Monotherapy and Polypharmacy in Schizophrenia: A 3-Years Follow-Up “Real World” Study in China
por: Zhang, Lei, et al.
Publicado: (2022)

Cinemotion, a Program of Cognitive Remediation to Improve the Recognition and Expression of Facial Emotions in Schizophrenia: A Pilot Study
por: Sevos, Jessica, et al.
Publicado: (2018)

Common and Distinct Alterations of Cognitive Function and Brain Structure in Schizophrenia and Major Depressive Disorder: A Pilot Study
por: Ma, Mengying, et al.
Publicado: (2021)

Reversible Changes in BDNF Expression in MK-801-Induced Hippocampal Astrocytes Through NMDAR/PI3K/ERK Signaling
por: Yu, Wenjuan, et al.
Publicado: (2021)

Using EEG-Guided Basket and Umbrella Trials in Psychiatry: A Precision Medicine Approach for Cognitive Impairment in Schizophrenia
por: Joshi, Yash B., et al.
Publicado: (2018)

Effects of Cognitive Remediation on Cognition, Metacognition, and Social Cognition in Patients With Schizophrenia
por: Montemagni, Cristiana, et al.
Publicado: (2021)

Chronic Stress Disturbs Metabolome of Blood Plasma and Urine in Diabetic Rats
por: Ren, Yu, et al.
Publicado: (2018)

Cognitive Remediation for Schizophrenia with Focus on NEAR
por: Mogami, Tamiko
Publicado: (2018)

White Matter Measures and Cognition in Schizophrenia
por: Erkol, Cemre, et al.
Publicado: (2020)

Plasma Metabolomics Profiling of Metabolic Pathways Affected by Major Depressive Disorder
por: Du, Yue, et al.
Publicado: (2021)

The Impact of Aging, Psychotic Symptoms, Medication, and Brain-Derived Neurotrophic Factor on Cognitive Impairment in Japanese Chronic Schizophrenia Patients
por: Atake, Kiyokazu, et al.
Publicado: (2018)

Case report: Recovery of hallucinations and cognitive impairment after administration of donepezil in a patient with schizophrenia and carbon monoxide poisoning
por: Baek, Seon-Hwa, et al.
Publicado: (2022)

Non-targeted Metabolomics Profiling of Plasma Samples From Patients With Major Depressive Disorder
por: Wu, Zhonghao, et al.
Publicado: (2022)

Enhancing Neuroplasticity to Augment Cognitive Remediation in Schizophrenia
por: Jahshan, Carol, et al.
Publicado: (2017)

Early Trauma and Cognitive Functions of Patients With Schizophrenia
por: Carrilho, Carolina G., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t8qe9uf74dcn5cmsfaqabepgp9